Hjem › Kardiovaskulær sykdom › Minnesota › Minneapolis
Kliniske studier for Kardiovaskulær sykdom i Minneapolis, MN
15 studier for Kardiovaskulær sykdom søker deltakere på steder i og rundt Minneapolis (innen ca. 30 miles). Åpne et studie for å se hvem som kan delta og hvordan du kontakter studieteamet.
Offisiell studietekst (engelsk)
Rekrutterer til et studie her? Få det fremtredende øverst på siden – $99 i 30 dager →
ELEVATE-HFpEF Clinical Study
Rekrutterer
- M Health Fairview University of Minnesota Medical Center - East Bank, Minneapolis
A Prospective, Multicenter, Randomized Controlled Trial to Investigate the Value of Coronary CT Angiography in the Understanding and Management of Coronary Calcium (The Optimal Trial)
Rekrutterer
- Minneapolis Heart Institute, Minneapolis
Product Surveillance Registry
RekruttererObservasjonsstudie
- Minneapolis, Minneapolis
Transcatheter Mitral Valve Replacement With the Medtronic Intrepid™ TMVR System in Patients With Severe Symptomatic Mitral Regurgitation.
Rekrutterer
- Abbott Northwestern Hospital, Minneapolis
Investigation of the BrioVAD System for the Treatment of Left Ventricular Heart Failure
Rekrutterer
- Abbott Northwestern Hospital, Minneapolis
- University of Minnesota, Minneapolis
A Study About How Blood Cell Growth Patterns Relate to Heart Health After Treatment for Hodgkin Lymphoma
RekruttererObservasjonsstudie
- Children's Hospitals and Clinics of Minnesota - Minneapolis, Minneapolis
A Phase III Study of AZD0780 on Major Adverse CV Events in Patients With a History of ASCVD Events or at High Risk for a First Event
RekruttererFase 3
- Research Site, Minneapolis
- Research Site, Minneapolis
OCEAN(a)-PreEvent - Olpasiran Trials of Cardiovascular Events And LipoproteiN(a) Reduction to Prevent First Major Cardiovascular Events
RekruttererFase 3
- University of Minnesota, Minneapolis
- Methodist Hospital, Saint Louis Park · 5 mi unna
VDyne Transcatheter Tricuspid Valve Replacement Study to Evaluate Safety and Clinical Efficacy in Patients With Symptomatic Severe Tricuspid Valve Regurgitation (TRIVITA Pivotal Trial)
Rekrutterer
- Minneapolis Heart Institute Foundation, Minneapolis
The TRICURE EFS Study
Rekrutterer
- Minneapolis Heart Institute Foundation, Minneapolis
PROACTIVE-HF-2 Trial Heart Failure NYHA Class II and III
Rekrutterer
- University of Minnesota, Minneapolis
Trial to Evaluate Safety And Effectiveness of Mechanical Circulatory Support in Patients With Advancing Heart Failure
Rekrutterer
- Minneapolis Heart Institute, Minneapolis
CSP #2026 - Beta Blocker Dialyzability on Cardiovascular Outcomes
RekruttererFase 3
- Minneapolis VA Health Care System, Minneapolis, MN, Minneapolis
Effect of Empagliflozin on Left Atrial Function in Adults at Risk for Heart Failure
RekruttererTidlig fase 1
- University of Minnesota, Minneapolis
MagicTouch for Treatment of In-Stent Restenosis in Coronary Artery Lesions
Rekrutterer
- Minneapolis Heart Institute Foundation, Minneapolis
Kardiovaskulær sykdom-studier i andre byer
- Boston, MA37 studier
- New York City, NY33 studier
- Washington, DC28 studier
- Houston, TX24 studier
- Dallas, TX23 studier
- Atlanta, GA22 studier
- Cleveland, OH22 studier
- Chicago, IL21 studier
- Philadelphia, PA21 studier
- Pittsburgh, PA20 studier
- St. Louis, MO20 studier
- Nashville, TN18 studier
Andre studier i Minneapolis
- Ikke-småcellet lungekreft27 studier
- Brystkreft27 studier
- Eggstokkreft24 studier
- Prostatakreft23 studier
- Kreft (alle typer)22 studier
- Hjertesvikt21 studier
- Akut myelogen leukemi20 studier
- Lungekreft20 studier
- Kolorektal kreft19 studier
- Endometriekreft18 studier
- Parkinsons sykdom17 studier
- Koronararteriesykdom13 studier
Fra ClinicalTrials.gov, data hentet 6. okt. 2026. Hver studie setter sine egne kvalifikasjonskrav; studieteamet avgjør hvem som kan delta.